1. A biodegradable rectal balloon implant to protect the rectum during prostate cancer radiotherapy for a patient with active Crohn's disease. (June 2018) Authors: Vanneste, Ben G.L.; Van Limbergen, Evert J.; van de Beek, Kees; van Lin, Emile; Lutgens, Ludy; Lambin, Philippe Journal: Technical innovations & patient support in radiation oncology Issue: Volume 6(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial. Issue 3 (March 2015) Authors: Aluwini, Shafak; Pos, Floris; Schimmel, Erik; van Lin, Emile; Krol, Stijn; van der Toorn, Peter Paul; de Jager, Hanja; Dirkx, Maarten; Alemayehu, Wendimagegn Ghidey; Heijmen, Ben; Incrocci, Luca Journal: Lancet oncology Issue: Volume 16:Issue 3(2015:Mar.) Page Start: 274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial. Issue 3 (March 2015) Authors: Aluwini, Shafak; Pos, Floris; Schimmel, Erik; van Lin, Emile; Krol, Stijn; van der Toorn, Peter Paul; de Jager, Hanja; Dirkx, Maarten; Alemayehu, Wendimagegn Ghidey; Heijmen, Ben; Incrocci, Luca Journal: Lancet oncology Issue: Volume 16:Issue 3(2015:Mar.) Page Start: 274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗